Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2022
Upgrades For Sensei Biotherapeutics Inc (NASDAQ:SNSE), Oppenheimer upgraded the previous rating of Perform to Outperform. For the second quarter, Sensei Biotherapeutics had an EPS of $0.34, compared t
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
US Top Rating Updates on 10/3: WFC, ADBE, MU, STX and More
Oppenheimer Upgrades to Outperform from Perform - PT $5.
RBC Upgrades CF Industries Holdings to Outperform From Sector Perform, Raises Price Target to $135 From $110, Cites Favorable Nitrogen Outlook, 'Strong' Operations
08:18 AM EDT, 10/03/2022 (MT Newswires) -- CF Industries Holdings (CF) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $78 to $135.
Exchange Traded Concepts LLC Acquires Shares of 7,343 CF Industries Holdings, Inc. (NYSE:CF)
Exchange Traded Concepts LLC acquired a new stake in CF Industries Holdings, Inc. (NYSE:CF – Get Rating) during the 2nd quarter, according to the company in its most recent filing with the SEC. The
CF Industries Price Target Raised to $135.00/Share From $110.00 by RBC Capital
CF Industries Holdings Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 10/03/2022 40.01% RBC Capital $110 → $135 Upgrades Sector Perform → Outperform 08/10/2022 24.46% Barclays
RBC Capital Upgrades CF Industries Holdings to Outperform, Raises Price Target to $135
RBC Capital analyst Andrew Wong upgrades CF Industries Holdings (NYSE:CF) from Sector Perform to Outperform and raises the price target from $110 to $135.
RBC Upgrades CF Industries on Favourable Nitrogen Outlook
Wealthfront Advisers LLC Has $1.92 Million Holdings in CF Industries Holdings, Inc. (NYSE:CF)
Wealthfront Advisers LLC increased its holdings in CF Industries Holdings, Inc. (NYSE:CF – Get Rating) by 20.5% during the second quarter, according to its most recent 13F filing with the Securities